Complement activation and cytokine response by BioProtein, a bacterial single cell protein

Clinical and Experimental Immunology

Volumn 148, Issue 1, 2007, Pages 146-152

  Sikkeland, L I B ^a,b   Thorgersen, E B ^b   Haug, T ^a   Mollnes, T E ^b,c,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORDLAND HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Bacteria; Complement; Cytokines interleukins; Endotoxin LPS; Inflammation

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; BACTERIAL CELL; BLOOD ANALYSIS; BLOOD CLOTTING; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VITRO STUDY; INFLAMMATION; METHYLOCOCCUS CAPSULATUS; NONHUMAN; PRIORITY JOURNAL; SERUM;

BACTERIAL PROTEINS; CHEMOKINES; COMPLEMENT ACTIVATION; CYTOKINES; DIETARY PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GROWTH SUBSTANCES; HUMANS; TISSUE CULTURE TECHNIQUES;

EID: 33847613819     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03339.x     Document Type: Article

References (26)

1. Skogstad M, Eduard W, Holme J, Qvenild T, Einarsdottir E. Short term changes in lung function, leukocytosis in blood, and lachrymal fluid among bacterial single cell protein workers after an episode with high exposure to endotoxins. Occup Environ Med 2005; 62:576-80.
2. Christensen HR, Larsen LC, Frokiaer H. The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature. Br J Nutr 2003; 90:169-78.
3. Molck AM, Poulsen M, Christensen HR, Lauridsen ST, Madsen C. Immunotoxicity of nucleic acid reduced BioProtein - a bacterial derived single cell protein inWistar rats. Toxicology 2002; 174:183-200.
4. Nuijens JH, Huijbregts CC, Eerenberg Belmer AJ et al. Quantification of plasma factor XIIa-Cl-inhibitor and kallikrein-Cl-inhibitor complexes in sepsis. Blood 1988; 72:1841-8.
5. Wolbink GJ, Bollen J, Baars JW et al. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Meth 1993; 163:67-76.
6. Mollnes TE, Brekke OL, Fung M et al. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002; 100:1869-77.
7. Mollnes TE, Lea T, Frøland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22:197-202.
8. Mollnes TE, Redl H, Hogasen K et al. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/ iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol 1993; 91:295-300.
9. Butko P, Nicholson-Weller A, Wessels MR. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J Immunol 1999; 163:2761-8.
10. Brown JS,Hussell T, Gilliland SMet al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad USA 2002; 99:16969-74.
11. Estabrook MM, Jack DL, Klein NJ, Jarvis GA. Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. J Immunol 2004; 172:3784-92.
12. Liu Y, Endo Y, Iwaki D et al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 2005; 175:3150-6.
13. Atkinson JP, Farries T. Separation of self from non-self in the complement system. Immunol Today 1987; 8:212-15.
14. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 2004; 138:439-46.
15. Sprong T, Moller AS, Bjerre A et al. Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect Immun 2004; 72:3344-9.
16. Dery RE, Lin TJ, Befus AD et al. Redundancy or cell-type-specific regulation? Tumour necrosis factor in alveolar macrophages and mast cells. Immunology 2000; 99:427-34.
17. Lin G, Pearson AE, Scamurra RWet al. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J Biol Chem 1994; 269:77-85.
18. Talwar S, Munson PJ, Barb J et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genom 2006; 25:203-15.
19. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170:2106-12.
20. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116:1218-22.
21. Ma XT, Zhang XJ, Zhang B et al. Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers. Cell Biol Int 2004; 28:689-97.
22. Stark MA, Huo Y, Burcin TL,Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005; 22:285-94.
23. Pilette C, Ouadrhiri Y, Van SJ et al. Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur Respir J 2002; 20:1198-205.
24. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998; 16:27-55.
25. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290:L209-L221.
26. Goto H, Rylander R. Kinetics of inhaled lipopolysaccharide in the guinea pig. J Lab Clin Med 1987; 110:287-91.